Patient Care Plans

Recommended for patients with BMI ≥ 30 or ≥ 27with obesity-related comorbidity

FDA Approved medications for weight loss: 

• Liraglutide (Saxenda)
• Naltrexone-Bupropion (Contrave)
• Orlistat
• Phentermine Topiramate (Qsymia)
• Semaglutide (Wegovy)

How to choose your med:

‍

General Advice Regarding Medications:

1. Ensure patient is not pregnant and (particularly if using Topiramate) is not at risk for pregnancy
2. Ensure patient does not have other contraindication to medications
3. Ensure patient has informed consent regarding
   a.  Off label use of the medication (if applicable)
   b.  Need for long-term use/acknowledgement that stopping med is likely to be associated with weight regain
4. If patient has not lost at least 5% body weight after 3 months on max dose of the medication, recommend stopping the medication and considering an alternative therapy
5. Recommend continuing the medication as long as it is effective and not contraindicated.

Find out if your patient’s insurance company covers Anti-Obesity Medications (AOMs)

We recommend getting this information before completing a prior authorization to use time efficiently, as many insurance companies have clear exclusion policies for AOMs. 

• NovoCare for Patient Affordability [Visit Website] >>
• Formulary Lookup (account set up required) [Visit Website] >>
• ‍Clarivate Fingertip Formulary Lookup (account set up required) [Visit Website] >>‍